Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuhua Fu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Oncology Reports|November 29, 2018
BAI1‑associated protein 2‑like 2 is a potential biomarker in lung cancerLei Xu, Hua Du, Qiang Zhang, et al.
Optics Express|June 11, 2026
Compact high-Q multimode InGaAsP/InP microring resonators enabled by mode-selective excitationGuannan Lv, Tianyu Sun, Xiuhua Fu, et al.
BMC Infectious Diseases|July 2, 2025
Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multicentre clinical trialDi Wu, Xiuhua Fu, Faguang Jin, et al.
Scientific Reports|February 6, 2019
INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatmentJiangtao Lin, Xiuhua Fu, Ping Jiang, et al.
BMC Pulmonary Medicine|April 11, 2020
Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthmaJiangtao Lin, Xiuhua Fu, Ping Jiang, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 25, 2023
Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE studyJinping Zheng, Jianyong Zhang, Xiuhua Fu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 24, 2025
Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia-Pacific RegionQingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Annals of Translational Medicine|May 14, 2021
Plasma <i>EGFR</i> mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancerXiaohong Wang, Yonggang Liu, Zhiying Meng, et al.
Allergy|June 17, 2025
Role for Complement C5 in Eosinophilic Inflammation of Severe AsthmaCong Dong, Shaohua Lu, Zhenan Deng, et al.
Frontiers in Medicine|June 12, 2023
Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficultyZeguang Zheng, Kai Yang, Ni Liu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Oncology Reports|November 29, 2018
BAI1‑associated protein 2‑like 2 is a potential biomarker in lung cancerLei Xu, Hua Du, Qiang Zhang, et al.
Optics Express|June 11, 2026
Compact high-Q multimode InGaAsP/InP microring resonators enabled by mode-selective excitationGuannan Lv, Tianyu Sun, Xiuhua Fu, et al.
BMC Infectious Diseases|July 2, 2025
Efficacy and safety of inhaled ambroxol hydrochloride solution in patients with lower respiratory tract infectious diseases: a randomized, double-blind, placebo-controlled, multicentre clinical trialDi Wu, Xiuhua Fu, Faguang Jin, et al.
Scientific Reports|February 6, 2019
INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatmentJiangtao Lin, Xiuhua Fu, Ping Jiang, et al.
BMC Pulmonary Medicine|April 11, 2020
Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthmaJiangtao Lin, Xiuhua Fu, Ping Jiang, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 25, 2023
Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE studyJinping Zheng, Jianyong Zhang, Xiuhua Fu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 24, 2025
Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia-Pacific RegionQingling Zhang, Nanshan Zhong, Sahajal Dhooria, et al.
Annals of Translational Medicine|May 14, 2021
Plasma <i>EGFR</i> mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancerXiaohong Wang, Yonggang Liu, Zhiying Meng, et al.
Allergy|June 17, 2025
Role for Complement C5 in Eosinophilic Inflammation of Severe AsthmaCong Dong, Shaohua Lu, Zhenan Deng, et al.
Frontiers in Medicine|June 12, 2023
Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficultyZeguang Zheng, Kai Yang, Ni Liu, et al.
Pageof 4